Ju Wang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
-
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- Ubiquitin and proteasome pathways
Papers in ⓘ
-
- MicroRNA in disease regulation 7
- Cancer-related molecular mechanisms research 7
-
- Cancer Research and Treatments 2
- Co-authors
- Hao Chang (4 shared papers)Zhihong Zhao (3 shared papers)Shan Kuang (2 shared papers)Chaomin Sun (2 shared papers)Ge Liu (2 shared papers)Quancai Peng (1 shared paper)Shengfa Wang (2 shared papers)Caiyan Zhang (2 shared papers)
- Journals
- Biomedicine & Pharmacotherapy (3 papers)Cancer Research and Treatment (1 paper)Anti-Cancer Drugs (1 paper)International Journal of Oncology (1 paper)Tumor Biology (1 paper)
- Partner nations
- ChinaAustraliaKazakhstan
In The Last Decade
Ju Wang
22 papers receiving 692 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 420
- Molecular Biology 508
- Complementary and alternative medicine 30
- Oncology 75
- Pollution 31
Countries citing papers authored by Ju Wang
This map shows the geographic impact of Ju Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju Wang more than expected).
Fields of papers citing papers by Ju Wang
This network shows the impact of papers produced by Ju Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju Wang. The network helps show where Ju Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ju Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 93 | |
| 2 | 2015 | 76 | |
| 3 | 2016 | 74 | |
| 4 | 2019 | 60 | |
| 5 | 2017 | 58 | |
| 6 | 2019 | 48 | |
| 7 | MiR-182 promotes cell proliferation by suppressing FBXW7 and FBXW11 in non-small cell lung cancer. | 2018 | 45 |
| 8 | 2008 | 37 | |
| 9 | 2014 | 36 | |
| 10 | 2020 | 28 | |
| 11 | 2021 | 28 | |
| 12 | 2017 | 27 | |
| 13 | 2018 | 24 | |
| 14 | 2020 | 21 | |
| 15 | 2020 | 12 | |
| 16 | 2012 | 11 | |
| 17 | 2019 | 9 | |
| 18 | 2011 | 6 | |
| 19 | 2015 | 4 | |
| 20 | Correlation of the expression of pokemon with p14~(ARF) and bcl-2 and their effects on prognosis of non small cell lung cancer | 2008 | 2 |
About Ju Wang
Ju Wang is a scholar working on Cancer Research, Biotechnology, Virology, Molecular Biology and Molecular Medicine, having authored 22 papers that have together received 702 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (7 papers), Circular RNAs in diseases (6 papers), RNA modifications and cancer (5 papers), Environmental Toxicology and Ecotoxicology (2 papers), Cancer Research and Treatments (2 papers), Cell death mechanisms and regulation (2 papers) and Bioactive Natural Diterpenoids Research (1 paper). The work is most often cited by research in Cancer Research (420 citations), Molecular Biology (508 citations), Complementary and alternative medicine (30 citations), Oncology (75 citations) and Pollution (31 citations). Ju Wang has collaborated with scholars based in China, Australia and Kazakhstan. Frequent co-authors include Hao Chang, Zhihong Zhao, Shan Kuang, Chaomin Sun, Ge Liu, Quancai Peng, Shengfa Wang, Caiyan Zhang, Yanli Li and Hong Li. Their work appears in journals such as Biomedicine & Pharmacotherapy, Cancer Research and Treatment, Anti-Cancer Drugs, International Journal of Oncology and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.